In Consulting Services

PharmaNet offers a comprehensive range of early- and late-phase consulting services on topics including: international regulatory affairs; scientific and medical affairs; quality; risk management; chemistry, manufacturing and controls; as well as biopharmaceutical investor issues.

Biography

Jan Willem van der Velden, MD, FFPM

Senior Vice President, Global Safety and Pharmacovigilance
Obere Wiltisgasse 52

8700 Küsnacht
SWITZERLAND

Tel: 41 44 918 7514
Fax: 609 520 3674

E-mail: jwvandervelden@pharmanet.com

Expertise: Worldwide regulatory strategy, submissions, safety, compliance, and supply management

 

Dr. van der Velden has more than 29 years of experience, including 7 years in oncology trials at the Rotterdam Radiotherapeutic Institute, where he was in charge of cancer epidemiology and the coordination and assessment of experimental treatment research. He also served 16 years in global safety at Solvay and Yamanouchi Europe. At PharmaNet, he is in charge of drug safety, pharmacovigilance, risk-and-crisis management, and pharmacoepidemiology of pharmaceuticals and devices. Dr. van der Velden has written or co-written more than 120 publications, abstracts, and presentations for leading journals and conferences.

 

PharmaNet Development Group, Inc.504 Carnegie Center, Princeton, NJ 08540Tel 609 951 6800Fax 609 514 0390